Save the date for the ABCD Diabetes Update 2026. 📅✅

Next year's meeting will be held at the Telford International Centre on the 28 - 30 January 2026.

Registration will open shortly.

The Diabetes Update programme is an initiative for trainees in diabetes and endocrinology. It aims to cover the diabetes section of the training curriculum for diabetes and endocrinology issued by the Joint Royal Colleges of Physicians Training Board. It is also a great opportunity for more established clinicians to find out the latest updates in the area of diabetes.

The Diabetes Update programme is an initiative for trainees in diabetes and endocrinology. It aims to cover the diabetes section of the training curriculum for diabetes and endocrinology issued by the Joint Royal Colleges of Physicians Training Board. It is also a great opportunity for more established clinicians to find out the latest updates in the area of diabetes.

REGISTRATION FOR ABCD DIABETES UPDATE 2024 IS NOW CLOSED!

31st January - 2nd February 2024.

The Diabetes Update programme is a new initiative for trainees in diabetes and endocrinology. It aims to cover the diabetes section of the training curriculum for diabetes and endocrinology issued by the Joint Royal Colleges of Physicians Training Board. It is also a great opportunity for more established clinicians to find out the latest updates in the area of diabetes.

ABCD has been working with the In-Patient Diabetes lead for Diabetes UK, Prof Gerry Rayman, and a group of Specialists in Diabetes to produce much needed guidance describing the maintenance and delivery of specialist diabetes services during COVID-19.

The document is intended for those involved in delivering and redesigning diabetes services in the light of this pandemic. It recognises the importance of maintaining certain elements of the diabetes service which will be essential in reducing the burden on hospitals and supporting inpatient teams.

ABCD is setting up a nationwide audit of tirzepatide (Mounjaro) in real clinical use in the UK. The aim will be to ascertain whether the experience in real clinical use matches the data from phase 3 clinical trials.

About the ABCD tirzepatide audit

Please note this programme is subject to change